AMBS Amarantus Bioscience Holdings Inc (CE)

U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 24F-2
Annual Notice of Securities Sold
Pursuant to Rule 24f-2

Read instructions at end of Form
before preparing Form.
Please print or type.

1. Name and address of issuer:

TIAA-CREF Life Funds
730 Third Avenue
New York, NY 10017-3206

2. The name of each series or class of securities for which this Form is filed (If the Form is being filed for all series and classes of securities of the issuer, check the box but do not list series or classes:

x

3. Investment Company Act File Number:

811-08961

Securities Act File Number: 333-61759

4(a) Last day of fiscal year for which this Form is filed:

December 31, 2013

4(b) ? Check box if this notice is being filed late (i.e., more than 90 calendar days after the end of the issuer's fiscal year). (See Instruction A.2)

Note: If the Form is being filed late,
interest must be
paid on the registration fee due.

4(c) ? Check box if this is the last time the issuer will be filing this Form.

5. Calculation of registration fee:

(i) Aggregate sale price of securities sold during the fiscal year pursuant to section 24(f): $ 0

(ii) Aggregate price of securities redeemed or repurchased during the fiscal year:
$ (28,863,147)

(iii) Aggregate price of securities redeemed or repurchased during any prior fiscal year ending no earlier than October 11, 1995 that were not previously used to reduce registration fees payable to the Commission:
$ -0-

(iv) Total available redemption credits
[Add items 5(ii) and 5(iii)]:
$ (28,863,147)

(v) Net sales - if Item 5(i) is greater than Item 5(iv) [subtract Item 5(iv) from Item 5(i)]:
$ (28,863,147)

(vi) Redemption credits available for use in future years $ 0
- if Item 5(i) is less than Item
5(iv) [subtract Item 5(iv) from Item 5(i)]:

(vii) Multiplier for determining registra- tion fee (See Instruction C.9):
x.0001288

(viii)Registration fee due
[multiply Item 5(v) by Item 5(vii)] (enter "0" if no fee is due): =$ 0

6. Prepaid Shares

If the response to Item 5(i) was determined by deducting
an amount of securities that were registered under the
Securities Act of 1933 pursuant to rule 24e-2 as in effect
before [effective date of rescission of rule 24e-2],
then report the amount of securities (number of shares or
other units) deducted here: -0- . If there is a
number of shares or other units that were registered
pursuant to rule 24e-2 remaining unsold at the end of
the fiscal year for which this form is filed that are
available for use by the issuer in future fiscal years,
then state that number here: -0-
.

7. Interest due - if this Form is being filed more than 90 days after the end of the issuer's fiscal year (see Instruction D):

+$ -0-

8. Total of the amount of the registration fee due plus any interest due [line 5(viii) plus line 7]:

=$ -0-
9. Date the registration fee and any interest payment was sent to the Commission's lockbox depository:

CIK#: 0001068204
Method of Delivery: NA

? Wire Transfer
? Mail or other means

SIGNATURES

This report has been signed below by the following persons
on behalf of the issuer and in the capacities and on the
dates indicated.

By (Signature and Title)*

 /s/ Phillip G. Goff

Phillip G. Goff

Principal Financial Officer,
Principal Accounting Officer
and Treasurer

Date March 12, 2014

* Please print the name and title of the signing officer below the signature.

Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Mar 2024 to Apr 2024

Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Apr 2023 to Apr 2024